IP Library Granted Patent US 11,583,185
Granted Patent B2
US 11,583,185 · App. 15/939,538 · Granted Feb 21, 2023

Applications of hyperspectral laser speckle imaging

Inventors: Andrew Homyk (Belmont, CA); Jason Donald Thompson (Palo Alto, CA)
Assignee: Verily Life Sciences LLC
A61B5/0075A61B5/0059A61B5/0066A61B5/0082A61B5/02A61B5/026A61B5/0261A61B5/0295A61B5/681A61B5/72
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,583,185
App. No.
15/939,538
Granted
Feb 21, 2023
Kind
B2
Abstract

Systems and methods are provided for detecting the flow of blood or other fluids in biological tissue by illuminating the biological tissue with two or more beams of coherent light and detecting responsively emitted light. A difference in wavelength, coherence length, beam divergence, or some other property of the beams of illumination causes the beams to preferentially scatter from, be absorbed by, or otherwise interact with respective elements of the biological tissue. Flow properties in one or more regions of the biological tissue (e.g., a region with which both beams of light preferentially interact, a region with which only one of the beams preferentially interacts) could be determined based on detected responsively emitted light from the biological tissue. Variations in speckle patterns over time and/or space, Doppler shifts, or some other properties of the detected light could be used to determine the flow properties.

Claims (29)

1. A system comprising:

a light source, wherein the light source is configured to (i) emit a first beam of coherent illumination into a biological tissue and (ii) emit a second beam of coherent illumination into the biological tissue, wherein the first beam of coherent illumination and the second beam of coherent illumination differ with respect to at least one of wavelength, coherence length, or beam divergence;

a light sensor configured to receive light from the biological tissue emitted in response to illumination by the light source; and

a controller operably coupled to the light sensor and the light source, wherein the controller comprises a computing device programmed to perform controller operations comprising:

emitting the first beam of coherent illumination into the biological tissue using the light source;

detecting, using the light sensor, a first property of light received from the biological tissue in response to illumination by the first beam of coherent illumination, wherein detecting the first property of light received from the biological tissue in response to illumination by the first beam of coherent illumination comprises detecting a time-varying pattern of constructive and destructive interference in light received from blood in the biological tissue;

emitting the second beam of coherent illumination into the biological tissue using the light source;

detecting, using the light sensor, a second property of light received from the biological tissue in response to illumination by the second beam of coherent illumination; and

determining a location and a shape of a target structure in the biological tissue based on the first property of light received from the biological tissue in response to illumination by the first beam of coherent illumination and the second property of light received from the biological tissue in response to illumination by the second beam of coherent illumination, wherein the target structure comprises at least one of a tumor, a neoplasm, a cyst, an anastomosis, or an epileptic focus.

2. The system of claim 1 , wherein the light source comprises first and second lasers configured to emit the first beam of coherent illumination and the second beam of coherent illumination, respectively.

3. The system of claim 1 , wherein the first beam of coherent illumination and the second beam of coherent illumination have respective different first and second wavelengths.

4. The system of claim 3 , wherein the light source comprises a tunable laser configured to emit coherent illumination at at least the first wavelength and the second wavelength during respective at least two periods of time.

5. The system of claim 1 , wherein the first beam of coherent illumination and the second beam of coherent illumination have respective first and second coherence lengths.

6. The system of claim 5 , wherein the light source comprises a laser configured to emit coherent illumination at at least the first coherence length and the second coherence length by detuning a cavity of the laser during respective at least two periods of time.

7. The system of claim 1 , wherein the first beam of coherent illumination and the second beam of coherent illumination have respective specified wavelengths, wherein the specified wavelengths are between 400 nanometers and 1000 nanometers.

8. The system of claim 1 , wherein the light source is configured to emit the first beam of coherent illumination such that the first beam of coherent illumination is polarized in a first direction, and further comprising a polarization filter.

9. The system of claim 1 , wherein the target structure comprises the tumor.

10. A method comprising:

emitting a first beam of coherent illumination into a biological tissue;

detecting a first property of light received from the biological tissue in response to illumination by the first beam of coherent illumination, wherein detecting the first property of light received from the biological tissue in response to illumination by the first beam of coherent illumination comprises detecting a time-varying pattern of constructive and destructive interference in light received from blood in the biological tissue;

emitting a second beam of coherent illumination into the biological tissue, where the second beam of coherent illumination differs from the first beam of coherent illumination with respect to at least one of wavelength, coherence length, or beam divergence;

detecting a second property of light received from the biological tissue in response to illumination by the second beam of coherent illumination; and

determining a location and a shape of a target structure in the biological tissue based on the first property of light received from the biological tissue in response to illumination by the first beam of coherent illumination and the second property of light received from the biological tissue in response to illumination by the second beam of coherent illumination, wherein the target structure comprises at least one of a tumor, a neoplasm, a cyst, an anastomosis, or an epileptic focus.

11. The method of claim 10 , wherein emitting the first beam of coherent illumination comprises emitting light from a first laser of a light source and emitting the second beam of coherent illumination comprises emitting light from a second laser of the light source.

12. The method of claim 11 , wherein emitting the first beam of coherent illumination comprises emitting light from the first laser during a first period of time and wherein emitting the second beam of coherent illumination comprises emitting light from the second laser during a second period of time that is non-overlapping with the first period of time.

13. The method of claim 10 , wherein the first beam of coherent illumination and the second beam of coherent illumination are emitted at the same time.

14. The method of claim 10 , wherein the first beam of coherent illumination and the second beam of coherent illumination have respective different first and second wavelengths.

15. The method of claim 10 , wherein the first beam of coherent illumination and the second beam of coherent illumination have respective different first and second coherence lengths.

16. The method of claim 10 , wherein the target structure comprises the tumor.

Assignments (4)
CHANGE OF NAME Recorded Apr 1, 2026
From: VERILY LIFE SCIENCES LLC
To: VERILY HEALTH INC.
Reel/Frame 075367/0775 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2022
From: HOMYK, ANDREW; THOMPSON, JASON DONALD
To: GOOGLE INC.
Reel/Frame 061643/0857 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2022
From: GOOGLE INC.
To: GOOGLE LIFE SCIENCES LLC
Reel/Frame 061876/0672 →
CHANGE OF NAME Recorded Nov 3, 2022
From: GOOGLE LIFE SCIENCES LLC
To: VERILY LIFE SCIENCES LLC
Reel/Frame 061877/0098 →
Cited By (2)
US 12,484,796 US 12,685,449